A locally-built, LLM-digested index of recent arXiv papers in quant finance, geometry/topology, and statistical ML — keyword search served straight from SQLite on this machine.
Optimizes treatment duration to maximize quality-adjusted lifetime.
problem Balancing risks and benefits in clinical decision making.
method Proposes a weighted estimating equation to adjust for confounding and informative censoring, and a nonparametric estimator for mean counterfactual quality-adjusted lifetime.
result Shows the optimal time for percutaneous endoscopic gastrostomy insertion in ALS patients.
A censored transformed model for proportional outcomes with boundary mass and an application to loss given default modeling.
problem Modeling proportional outcomes with boundary mass in loss given default (LGD) modeling.
method Zero-one censored transformed normal (ZOC-TN) model.
result Captures a wider range of qualitative density shapes than benchmark models while being parsimonious, computationally efficient, and numerically stable.
Random forest models predict CLABSI risk in hospital admissions, with static models performing similarly to dynamic ones.
problem Predicting CLABSI risk in hospital admissions using EHR data with competing risks.
method Comparison of static and dynamic random forest models for binary, multinomial, survival, and competing risks outcomes.
result Static and dynamic random forest models perform similarly in predicting CLABSI risk, with multinomial models having the lowest computation times.
ICODEN models survival data with interval-censored times using neural networks and ODEs.
problem Predicting time-to-event outcomes with interval-censored data, especially when models require strong assumptions or cannot handle high-dimensional predictors.
method ICODEN uses ordinary differential equations and deep neural networks to model the hazard function and cumulative hazard without proportional hazards assumption.
result ICODEN achieves satisfactory predictive accuracy across various simulation and real-world applications, handling high-dimensional predictors robustly.
Predicting an individual's risk of experiencing a future clinical outcome is a statistical task with important consequences for both practicing clinicians and public health experts. Modern observational databases such as electronic health records (EHRs) provide an alternative to the longitudinal cohort studies traditio…
Models for predicting the risk of cardiovascular events based on individual patient characteristics are important tools for managing patient care. Most current and commonly used risk prediction models have been built from carefully selected epidemiological cohorts. However, the homogeneity and limited size of such coho…
Causal inference analysis is the estimation of the effects of actions on outcomes. In the context of healthcare data this means estimating the outcome of counter-factual treatments (i.e. including treatments that were not observed) on a patient's outcome. Compared to classic machine learning methods, evaluation and val…
Accurately predicting the time of occurrence of an event of interest is a critical problem in longitudinal data analysis. One of the main challenges in this context is the presence of instances whose event outcomes become unobservable after a certain time point or when some instances do not experience any event during …
Modeling continuous-time physiological processes that manifest a patient's evolving clinical states is a key step in approaching many problems in healthcare. In this paper, we develop the Hidden Absorbing Semi-Markov Model (HASMM): a versatile probabilistic model that is capable of capturing the modern electronic healt…
The Brier score is commonly used for evaluating probability predictions. In survival analysis, with right-censored observations of the event times, this score can be weighted by the inverse probability of censoring (IPCW) to retain its original interpretation. It is common practice to estimate the censoring distributio…
In both the fields of computer science and medicine there is very strong interest in developing personalized treatment policies for patients who have variable responses to treatments. In particular, I aim to find an optimal personalized treatment policy which is a non-deterministic function of the patient specific cova…